Boston Trust Walden Corp Cuts Position in Plexus Corp. (NASDAQ:PLXS)

Boston Trust Walden Corp lessened its position in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 1.6% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 378,248 shares of the technology company's stock after selling 6,036 shares during the period. Boston Trust Walden Corp owned about 1.40% of Plexus worth $48,465,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of PLXS. American Century Companies Inc. boosted its holdings in shares of Plexus by 72.2% in the 4th quarter. American Century Companies Inc. now owns 544,017 shares of the technology company's stock valued at $85,128,000 after buying an additional 228,027 shares in the last quarter. GAMMA Investing LLC raised its position in Plexus by 19,069.1% in the 1st quarter. GAMMA Investing LLC now owns 170,797 shares of the technology company's stock valued at $21,884,000 after purchasing an additional 169,906 shares during the last quarter. Fuller & Thaler Asset Management Inc. purchased a new stake in Plexus in the 4th quarter valued at $24,747,000. JPMorgan Chase & Co. raised its position in Plexus by 146.9% in the 4th quarter. JPMorgan Chase & Co. now owns 258,824 shares of the technology company's stock valued at $40,501,000 after purchasing an additional 154,003 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its position in Plexus by 1,875.1% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 137,466 shares of the technology company's stock valued at $21,511,000 after purchasing an additional 130,506 shares during the last quarter. Institutional investors and hedge funds own 94.45% of the company's stock.

Insiders Place Their Bets

In other news, CEO Todd P. Kelsey sold 1,000 shares of the stock in a transaction dated Friday, May 23rd. The shares were sold at an average price of $130.00, for a total transaction of $130,000.00. Following the transaction, the chief executive officer now directly owns 78,714 shares in the company, valued at $10,232,820. This represents a 1.25% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Angelo Michael Ninivaggi, Jr. sold 2,058 shares of the firm's stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $132.22, for a total transaction of $272,108.76. Following the completion of the transaction, the chief accounting officer now owns 26,133 shares in the company, valued at $3,455,305.26. The trade was a 7.30% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 12,032 shares of company stock valued at $1,582,222 in the last ninety days. Insiders own 1.76% of the company's stock.

Plexus Price Performance

Shares of PLXS traded up $3.00 during trading hours on Monday, reaching $133.71. The company had a trading volume of 105,505 shares, compared to its average volume of 169,381. The firm has a 50 day simple moving average of $129.21 and a 200-day simple moving average of $137.82. The company has a current ratio of 1.53, a quick ratio of 0.71 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $3.62 billion, a price-to-earnings ratio of 26.01 and a beta of 0.81. Plexus Corp. has a 12-month low of $100.96 and a 12-month high of $172.89.

Plexus (NASDAQ:PLXS - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The technology company reported $1.66 EPS for the quarter, beating analysts' consensus estimates of $1.54 by $0.12. The firm had revenue of $980.17 million for the quarter, compared to analysts' expectations of $980.07 million. Plexus had a net margin of 3.60% and a return on equity of 11.17%. The firm's revenue was up 1.4% on a year-over-year basis. During the same period in the prior year, the company earned $0.94 EPS. Research analysts expect that Plexus Corp. will post 5.9 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts recently commented on PLXS shares. Benchmark reiterated a "buy" rating and issued a $160.00 price target on shares of Plexus in a research report on Wednesday, June 4th. Stifel Nicolaus set a $145.00 price target on shares of Plexus in a research report on Thursday, April 24th. Needham & Company LLC restated a "buy" rating and set a $162.00 price objective (down previously from $172.00) on shares of Plexus in a research report on Friday, April 25th. Finally, Wall Street Zen downgraded shares of Plexus from a "strong-buy" rating to a "buy" rating in a research report on Sunday. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $155.67.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.